España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Recent
Markets
John Eade
Boeing Analyst Turns Bullish After Deep Sell-Off
Argus Upgrades General Dynamics on Industry Turn, Price
Argus Downgrades Boeing On Near-Term 737 Max Risk
Argus Upgrades General Dynamics on Industry Turn, Price
Argus Downgrades Boeing On Near-Term 737 Max Risk
Argus Ups Boeing Target Price On Positive Industry Trends
Argus: Don't Shop For JCPenney Stock
Argus Ups Boeing Target Price On Positive Industry Trends
|
Argus: Don't Shop For JCPenney Stock
|
Parker-Hannifin's Concerning Outlook Prompts Argus To Move To The Sidelines
|
Sell-Side Analysts Respond To GE's Earnings Sell-Off
|
Read More...
John Eade Recent News
Near-Term Inflationary Trends Send Argus To Sidelines On Owens Corning
|
Argus Turns Neutral On Arconic Amid 'Challenging Outlook'
|
Argus: Colgate Shares Offer Investors Value
|
Hershey's Ongoing Margin Concerns Forces Argus To Downgrade Stock
|
Argus Steps To Sideline On Canadian National, Waits For Revenue Growth Or $70 Level
|
Argus Upgrades United Technologies, Points To Diversified Business Model
|
Argus Gives Medtronic Improved Prognosis, Expects Nearly 10% Future Growth
|
Analyst: Paccar Shares Keep On Trucking, Despite Recent Outperformance
|
The Pullback In Sanofi Is A Buying Opportunity, Says Argus
|
GlaxoSmithKline Recent Pullback Delivers A Healthy Opportunity To Buy
|
2 Stocks With Recent Pullbacks Argus Research Says Are Now A Buy
|
Analysts Split On CSX's Outlook Post Q2 Earnings
|
Argus Upgrades Vodafone After A Quarter That Delivered 6 Times The S&P 500's Performance
|
Investors May Have Just Found A Good Entry Point In Fastenal
|
Argus Crossing Over To A Hold Rating On Chicago Bridge & Iron
|
Analyst Says Teva Is 'Plagued With Problems,' Downgrades On Challenging Outlook
|
Stuck In A Bearish Trend, Johnson Controls Shares Would Look More Attractive In The Mid-$30s
|
Gannett's M&A Focus, Risk To Dividend And Weak Comps Lead Argus To Downgrade
|
Recent Selloff In Automatic Data Processing Creates Buying Opportunity
|
Recent Weakness In Honeywell Shares Offers Buying Opportunity
|
Recent Weakness In Lockheed Shares Offers Buying Opportunity
|
NY Times' Digital Sales Won't Make A Big Impact For At Least 4 Years
|
Weakness In Paychex Shares Has Created Buying Opportunity
|